Percheron Therapeutics has formed long-standing partnerships and collaborations with leading companies and research institutions.
Percheron looks for the best and brightest scientists and commercial people to develop its pipeline of rare and orphan disease therapies and it’s no different when looking for partnerships and collaborations. Our mission is to bring our therapies to patients in need.
Percheron is fortunate to have an established partnership with Ionis Pharmaceuticals, Inc (NADAQ: IONS), the acknowledged world-leader in antisense oligonucleotide drug development. Through this partnership, Percheron was granted access to Ionis antisense oligonucleotide drug assets ATL1102 and ATL1103.
Other valued collaborators are listed below.
Percheron will always strive to identify the best partnerships and collaborations to accelerate the development and commercialisation of its pipeline.
If interested in a partnership or collaboration with Percheron Therapeutics, please email us at info@PercheronTx.com
